Kodiak Sciences Inc (KOD)
3.775
+0.08
(+2.03%)
USD |
NASDAQ |
May 03, 16:00
3.775
0.00 (0.00%)
After-Hours: 19:04
Kodiak Sciences Max Drawdown (5Y): 99.15% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.15% |
| March 31, 2024 | 99.15% |
| February 29, 2024 | 99.15% |
| January 31, 2024 | 99.15% |
| December 31, 2023 | 99.15% |
| November 30, 2023 | 99.15% |
| October 31, 2023 | 99.15% |
| September 30, 2023 | 98.91% |
| August 31, 2023 | 98.66% |
| July 31, 2023 | 98.26% |
| June 30, 2023 | 97.39% |
| May 31, 2023 | 97.39% |
| April 30, 2023 | 97.34% |
| March 31, 2023 | 97.08% |
| February 28, 2023 | 96.94% |
| January 31, 2023 | 96.94% |
| December 31, 2022 | 96.94% |
| November 30, 2022 | 96.94% |
| October 31, 2022 | 96.94% |
| September 30, 2022 | 96.94% |
| August 31, 2022 | 96.94% |
| July 31, 2022 | 96.94% |
| June 30, 2022 | 96.94% |
| May 31, 2022 | 96.94% |
| April 30, 2022 | 96.45% |
| Date | Value |
|---|---|
| March 31, 2022 | 95.69% |
| February 28, 2022 | 94.75% |
| January 31, 2022 | 68.46% |
| December 31, 2021 | 53.06% |
| November 30, 2021 | 53.06% |
| October 31, 2021 | 53.06% |
| September 30, 2021 | 53.06% |
| August 31, 2021 | 53.06% |
| July 31, 2021 | 53.06% |
| June 30, 2021 | 53.06% |
| May 31, 2021 | 51.71% |
| April 30, 2021 | 50.19% |
| March 31, 2021 | 50.19% |
| February 28, 2021 | 50.19% |
| January 31, 2021 | 50.19% |
| December 31, 2020 | 50.19% |
| November 30, 2020 | 50.19% |
| October 31, 2020 | 50.19% |
| September 30, 2020 | 50.19% |
| August 31, 2020 | 50.19% |
| July 31, 2020 | 50.19% |
| June 30, 2020 | 50.19% |
| May 31, 2020 | 50.19% |
| April 30, 2020 | 50.19% |
| March 31, 2020 | 50.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
41.42%
Minimum
May 2019
99.15%
Maximum
Oct 2023
70.73%
Average
53.06%
Median
Jun 2021
Max Drawdown (5Y) Benchmarks
| Avalo Therapeutics Inc | 99.98% |
| Regeneron Pharmaceuticals Inc | 53.84% |
| iBio Inc | 99.97% |
| Puma Biotechnology Inc | 98.76% |
| Dare Bioscience Inc | 99.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.52 |
| Beta (5Y) | 2.247 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 125.4% |
| Historical Sharpe Ratio (5Y) | -0.1394 |
| Historical Sortino (5Y) | -0.2899 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.20% |